Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SPY
3. SKA-B
4. PBA
5. ALAR
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights

Aurinia Pharmaceuticals (AUPH) Reports In-Line Q1 EPS

May 14, 2020 4:34 PM EDT

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $50 thousand.

We are fortunate that the global COVID-19 pandemic has had minimal impact on Aurinias operations, and we have maintained our timelines to ensure the filing of the voclosporin NDA by the end of the... More